Valuation: Eckert & Ziegler SE

Market Cap 885M 1.01B 818M 751M 1.42B 97.54B 1.45B 9.76B 3.83B 47.63B 3.8B 3.72B 164B P/E 2026 *
16.9x
P/E 2027 * 15.7x
Enterprise Value 769M 880M 711M 653M 1.24B 84.8B 1.26B 8.48B 3.33B 41.41B 3.3B 3.23B 143B EV / Sales 2026 *
2.39x
EV / Sales 2027 * 2.2x
Free-Float
67.36%
Yield 2026 *
1.38%
Yield 2027 * 1.41%
1 day-1.00%
1 week-7.65%
Current month-9.87%
1 month-8.50%
3 months-11.08%
6 months-12.43%
Current year-8.92%
1 week 13.85
Extreme 13.85
14.97
1 month 13.85
Extreme 13.85
15.88
Current year 13.49
Extreme 13.49
16.58
1 year 13.49
Extreme 13.49
22.87
3 years 9.69
Extreme 9.6867
23
5 years 9.69
Extreme 9.6867
47.07
10 years 1.61
Extreme 1.6059
47.07
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-7.65% - - 1.01B
-0.99%+1.07%+16.20%-20.51% 17.53B
-6.27%-3.41%+0.47%+82.98% 1.67B
-4.66%-4.35%-34.50%-78.98% 1.24B
-4.06%+5.84%-27.53%-52.68% 672M
-7.46%-0.30%-40.81%-57.56% 576M
-1.58%-4.12%+34.97%-53.67% 453M
-1.65%+0.32%-54.31%-58.92% 387M
-3.29%+16.11%+47.89% - 332M
+6.73%+5.78%-18.94%-21.21% 338M
Average -2.43%+2.17%-8.51%-32.57% 2.58B
Weighted average by Cap. -1.76%+4.55%+8.80%-19.32%

Financials

2026 *2027 *
Net sales 322M 368M 297M 273M 517M 35.46B 526M 3.55B 1.39B 17.32B 1.38B 1.35B 59.78B 344M 394M 319M 292M 553M 37.97B 563M 3.8B 1.49B 18.54B 1.48B 1.45B 64.02B
Net income 52.28M 59.81M 48.35M 44.37M 83.97M 5.76B 85.43M 577M 227M 2.81B 225M 220M 9.72B 54.93M 62.85M 50.8M 46.62M 88.23M 6.06B 89.76M 606M 238M 2.96B 236M 231M 10.21B
Net Debt -116M -132M -107M -98.13M -186M -12.75B -189M -1.28B -501M -6.22B -497M -486M -21.49B -126M -144M -117M -107M -202M -13.89B -206M -1.39B -546M -6.78B -541M -529M -23.42B
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,100
Date Price Change Volume
26-07-17 13.88 -0.86% 214
26-07-16 €14.00 -2.64% 150
26-07-15 €14.38 -2.90% 100
26-07-14 €14.81 -1.07% 0
26-07-13 €14.97 -0.40% 600
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14.14EUR
Average target price
22.10EUR
Spread / Average Target
+56.29%

Quarterly revenue - Rate of surprise